Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older

Author： Roland Peter S   Ryan Matthew W   Wall G Michael  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.9, 2010-06, pp. : 1559-1567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olopatadine nasal spray significantly improves nose-related symptoms and QOL factors in patients with seasonal allergic rhinitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 496, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Fluticasone Furoate Nasal Spray Once Daily in Paediatric Patients Aged 6-11 Years with Allergic Rhinitis: Subanalysis of Three Randomized, Double-Blind, Placebo-Controlled, Multicentre Studies

By Meltzer Eli O.  

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 79-86

Adis International

Access to resources Recommend Favorite

Olopatadine improves symptoms, QOL in seasonal allergic rhinitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 451, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Olopatadine improves symptoms, QOL in seasonal allergic rhinitis

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Ciclesonide Nasal Spray: In Allergic Rhinitis

By Dhillon Sohita   Wagstaff Antona J.  

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 875-883

Adis International

Access to resources Recommend Favorite